Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01667354 · ClinicalTrials.gov registry record · NA
Vaccine Hesitancy Intervention--Provider (VHIP)
A NA study of Childhood Vaccination, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 491
- Enrollment target
- 1
- Study location
NCT01667354: Completed NA study of Childhood Vaccination, sponsored by Kaiser Permanente.
NCT01667354 is a NA study of Childhood Vaccination that has completed, run by Kaiser Permanente. The registered enrollment target is 491 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01667354, a NA study of Childhood Vaccination, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 491 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy.
Primary Outcome
The investigators will contact mothers of newborns in study practices and conduct a telephone survey at two time points: baseline and 6 months. Surveys will assess parental hesitancy, parental trust in provider, and other covariates such as perceived social norms, other sources of information about vaccines, and demographic information.
Conditions Studied
Interventions
- BEHAVIORAL Academic Detailing
Study Locations (1)
Washington
- Group Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 491 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01667354 record still lists
NCT01667354 is an interventional study that assigns participants to a tested intervention. The registered 491 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Childhood Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Academic Detailing is the first listed.
NCT01667354 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01667354 about?
NCT01667354 is a clinical study titled "Vaccine Hesitancy Intervention--Provider (VHIP)". The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy.
What is the current status of trial NCT01667354?
This trial is currently completed. It is a NA study. The enrollment target is 491 participants. The study started on 2012-02. Estimated completion is 2014-04.
What conditions does trial NCT01667354 study?
This clinical trial studies the following conditions: Childhood Vaccination.
What interventions are being tested in trial NCT01667354?
The interventions under investigation include: Academic Detailing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01667354?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01667354 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01667354's enrollment target sits among peer trials
491 215th of 2000 higher than 1,786 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03418961 · 491 participants · Phase 3
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06152575 · 492 participants · Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia